Chan Henry Lee Sells 1,202 Shares of Beigene, Ltd. (NASDAQ:ONC) Stock

Beigene, Ltd. (NASDAQ:ONCGet Free Report) SVP Chan Henry Lee sold 1,202 shares of the firm’s stock in a transaction dated Friday, February 21st. The stock was sold at an average price of $258.04, for a total transaction of $310,164.08. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Beigene Trading Up 0.5 %

Beigene stock traded up $1.21 during midday trading on Tuesday, reaching $259.70. The stock had a trading volume of 619,630 shares, compared to its average volume of 378,820. The stock has a market capitalization of $25.41 billion, a P/E ratio of -31.52, a P/E/G ratio of 7.73 and a beta of 0.63. Beigene, Ltd. has a 12 month low of $126.97 and a 12 month high of $265.89. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.72 and a current ratio of 1.93.

About Beigene

(Get Free Report)

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.

Featured Stories

Receive News & Ratings for Beigene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beigene and related companies with MarketBeat.com's FREE daily email newsletter.